CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Asensus Surgical, Inc. - ASXC CFD

0.3353
0%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0037
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.3353
Open 0.334
1-Year Change -43.01%
Day's Range 0.334 - 0.3384
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 19, 2024 0.3353 0.0011 0.33% 0.3342 0.3387 0.3340
Jul 18, 2024 0.3353 -0.0023 -0.68% 0.3376 0.3379 0.3343
Jul 17, 2024 0.3363 0.0003 0.09% 0.3360 0.3383 0.3360
Jul 16, 2024 0.3379 0.0015 0.45% 0.3364 0.3387 0.3363
Jul 15, 2024 0.3361 0.0009 0.27% 0.3352 0.3376 0.3343
Jul 12, 2024 0.3370 0.0028 0.84% 0.3342 0.3379 0.3280
Jul 11, 2024 0.3372 0.0048 1.44% 0.3324 0.3376 0.3303
Jul 10, 2024 0.3313 -0.0029 -0.87% 0.3342 0.3362 0.3263
Jul 9, 2024 0.3329 -0.0016 -0.48% 0.3345 0.3365 0.3323
Jul 8, 2024 0.3324 -0.0018 -0.54% 0.3342 0.3368 0.3310
Jul 5, 2024 0.3323 0.0025 0.76% 0.3298 0.3365 0.3296
Jul 3, 2024 0.3309 0.0029 0.88% 0.3280 0.3351 0.3261
Jul 2, 2024 0.3336 0.0072 2.21% 0.3264 0.3341 0.3264
Jul 1, 2024 0.3313 0.0063 1.94% 0.3250 0.3341 0.3250
Jun 28, 2024 0.3306 0.0064 1.97% 0.3242 0.3339 0.3242
Jun 27, 2024 0.3274 0.0006 0.18% 0.3268 0.3315 0.3206
Jun 26, 2024 0.3295 0.0044 1.35% 0.3251 0.3318 0.3221
Jun 25, 2024 0.3273 0.0055 1.71% 0.3218 0.3299 0.3196
Jun 24, 2024 0.3263 0.0042 1.30% 0.3221 0.3292 0.3202
Jun 21, 2024 0.3273 0.0059 1.84% 0.3214 0.3273 0.3213

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Asensus Surgical, Inc. Company profile

Asensus Surgical (ASXC) is a medical device company that engages in digitising the interface between the surgeon and the patient to improve minimally invasive surgery (MIS). 

Founded in 2006, Asensus is headquartered in Durham, North Carolina. It pioneers a new era of performance-guided surgery, using advanced capabilities, like machine vision, augmented intelligence, connectivity and robotics in laparoscopy. 

Asensus has built the foundation of Digital Laparoscopy with the help of its Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to address clinical, cognitive and economic shortcomings in surgery.

The Senhance Surgical System is a multi-port robotic system that provides enhanced control with surgeon eye-tracking camera control & 3D (three dimensional) HD (high definition) vision and enhances precision through tremor filtrations and robotic stabilisation. Additionally, surgeons can have enhanced focus during surgery through Asensus’s optimised ergonomics and the sense of touch (haptics). 

The surgical device that consists of a robotic instrument and a camera for laparoscopic procedures is considered to be the smallest instrument offered in robotics, leading to smaller incisions than traditional robotic surgery. Asensus’ Senhance ultrasonic system is an advanced energy device to deliver controlled energy to ligate and divide tissue.

Asensus Surgical previously developed the SPIDER device and the SurgiBot System. It changed its name from TransEnterix in February 2021. The company went public as TransEnterix in May 2014. It trades on the NYSE American under the ticker ‘ASXC’.

Industry: Medical Equipment, Supplies & Distribution (NEC)

1 Tw Alexander Drive
Suite 160
DURHAM
NORTH CAROLINA 27703
US

People also watch

Gold

2,401.36 Price
-1.830% 1D Chg, %
Long position overnight fee -0.0198%
Short position overnight fee 0.0116%
Overnight fee time 21:00 (UTC)
Spread 1.20

BTC/USD

67,261.80 Price
+0.300% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,526.60 Price
-1.140% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

XRP/USD

0.60 Price
+3.830% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading